Press Releases Provincial drug plans adding new lymphoma treatment is good news for patients, but other promising cancer therapies still awaiting green light
Research Obinutuzumab (GA101) Significantly Improved Progression-Free Survival in People With Chronic Lymphocytic Leukemia (CLL)
